Covid | 'Oxford vaccine's late stage trials to start in a week in India': ICMR

Video Credit: HT Digital Content
Published on August 4, 2020 - Duration: 06:42s

Covid | 'Oxford vaccine's late stage trials to start in a week in India': ICMR

At present country has three Indian COVID-19 vaccines which are in different phases of clinical testing, said Indian Council of Medical Research (ICMR) Director General Dr Balram Bhargava on Tuesday.

Addressing a press conference in the national capital, he said, "At the present moment, we have three Indian vaccines which are in different phases of clinical testing.

The 2 vaccines- Bharat Biotech vaccine and DNA vaccine of Zydus Cadila have completed phase 1 and will begin phase 2 while third is Oxford vaccine." "Oxford vaccine, being manufactured by Serum Institute of India (SII) got approval for phase 2 and 3 clinical trials, which are starting within a week at 17 sites," he added.

Dr Bhargava, however, said that social distancing and proper hygiene are the best "vaccine" available now and even after.

"Physical Distancing, wearing a mask, proper hand hygiene are the best vaccine available at the moment and even after.

We will have to continue with these measures," he said.

India has so far recorded over 18 lakh cases and more than 38,900 deaths.

Advertisement

You are here


๐Ÿ’ก One News Page Knowledge: Other News Mentions


ICMR said it has communicated to states the findings of a serosurvey in "dynamic containment zones" in 10 cities, which "do not fit into the..
Credit: IndiaTimes - Published 5 days ago

The Indian Council of Medical Research (ICMR) on Sunday (September 20, 2020) informed that second countrywide serosurvey for COVID-19 has been successfully..
Credit: DNA - Published 6 days ago


Serum Institute of India

Indian biotechnological company, vaccine manufacturer
The phase-III human clinical trial of the Covid-19 vaccine being developed by Oxford University, and manufactured by the Serum Institute of India (SII), began at..
Credit: IndiaTimes - Published 5 days ago



Bharat Biotech

Indian biotechnology company and vaccine manufacturer
The Uttar Pradesh government on Thursday announced that Phase-III trials of Bharat Biotech's coronavirus (COVID-19) vaccine 'COVAXIN' will start in Lucknow and..
Credit: DNA - Published 2 days ago

Credit: IndiaTimes - Published 3 days ago

Related videos from verified sources

Johnson & Johnson Begins Phase Three COVID-19 Vaccine Trials 02:09
Video credit: Cheddar Inc. - Published 20 hours ago 

Brazil hoping to roll out Coronavac vaccine in December 02:15
Video credit: Al Jazeera STUDIO - Published 1 day ago 

UK will deliberately infect vaccine volunteers: report 01:22
Video credit: Reuters Studio - Published 2 days ago 

You might like